<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Autolus Therapeutics plc

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Autolus Therapeutics plc

    Autolus is a clinical-stage, biopharmaceutical company, focused on the development and commercialisation of engineered T-cell immunotherapy products to combat cancer. Utilising its advanced cell programming and manufacturing technologies, Autolus has a pipeline of products in development for the treatment of both haematological malignancies and solid tumours. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $657,000,000
    • SIC CODE
      2836
    • NIN CODE
      ####
    • LEADERSHIP
      Dr. Christian Itin
    • FOUNDED
      2014
    • EMPLOYEES
      101-250
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Aptorum Group Limited

    Aptorum Group Limited

    We are a pharmaceutical company currently in the preclinical stage, dedicated to d...

    We are a pharmaceutical company currently in th...

    Filing Type:    PU
    Cyndescope, Inc.

    Cyndescope, Inc.

    Cyndescope Inc. is a technology company focusing on software solutions for the hea...

    Cyndescope Inc. is a technology company focusin...

    Fundraising Status:    EC
    Filing Type:    CF
    Harrow Health, Inc.

    Harrow Health, Inc.

    Harrow Health, Inc. (NASDAQ: HROW) owns a portfolio of healthcare businesses, incl...

    Harrow Health, Inc. (NASDAQ: HROW) owns a portf...

    Filing Type:    PU
    resTORbio, Inc.

    resTORbio, Inc.

    resTORbio, Inc. is a clinical-stage biopharmaceutical company developing innovativ...

    resTORbio, Inc. is a clinical-stage biopharmace...

    Filing Type:    PU
    Motif Bio plc

    Motif Bio plc

    Motif Bio is a clinical stage biopharmaceutical company developing novel antibioti...

    Motif Bio is a clinical stage biopharmaceutical...

    Filing Type:    PU
    CohBar, Inc.

    CohBar, Inc.

    CohBar, Inc. is a leader in the research and development of mitochondria based the...

    CohBar, Inc. is a leader in the research and de...

    Filing Type:    PU
    Rexahn Pharmaceuticals, Inc.

    Rexahn Pharmaceuticals, Inc.

    Rexahn Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to ...

    Rexahn Pharmaceuticals is a clinical stage biop...

    Filing Type:    PU
    TRACON Pharmaceuticals, Inc.

    TRACON Pharmaceuticals, Inc.

    TRACON Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused...

    TRACON Pharmaceuticals, Inc. is a clinical stag...

    Filing Type:    PU
    Spectrum Pharmaceuticals, Inc.

    Spectrum Pharmaceuticals, Inc.

    Spectrum Pharmaceuticals is a leading biotechnology company with a focus in Oncolo...

    Spectrum Pharmaceuticals is a leading biotechno...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.